Jeff Yass’s Lisata Therapeutics LSTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-11,604
| Closed | -$58.1K | – | 14059 |
|
|
2026
Q1 | $58.1K | Buy |
+11,604
| New | +$47.9K | ﹤0.01% | 12596 |
|
|
2024
Q4 | – | Sell |
-11,019
| Closed | -$33.1K | – | 12784 |
|
|
2024
Q3 | $33.1K | Buy |
+11,019
| New | +$34.7K | ﹤0.01% | 11512 |
|
|
2024
Q2 | – | Sell |
-10,719
| Closed | -$33.4K | – | 12741 |
|
|
2024
Q1 | $33.4K | Sell |
10,719
-23,030
| -68% | -$68.2K | ﹤0.01% | 11685 |
|
|
2023
Q4 | $92.1K | Buy |
+33,749
| New | +$79.2K | ﹤0.01% | 11393 |
|
|
2022
Q3 | – | Sell |
-864
| Closed | -$6.26K | – | 13740 |
|
|
2022
Q2 | $7K | Sell |
864
-1,736
| -67% | -$14.3K | ﹤0.01% | 12570 |
|
|
2022
Q1 | $28K | Buy |
2,600
+1,022
| +65% | +$11.7K | ﹤0.01% | 12531 |
|
|
2021
Q4 | $20K | Sell |
1,578
-15,537
| -91% | -$240K | ﹤0.01% | 12826 |
|
|
2021
Q3 | $313K | Buy |
17,115
+15,971
| +1,396% | +$313K | ﹤0.01% | 10508 |
|
|
2021
Q2 | $28K | Sell |
1,144
-5,674
| -83% | -$134K | ﹤0.01% | 12392 |
|
|
2021
Q1 | $197K | Buy |
6,818
+5,372
| +372% | +$163K | ﹤0.01% | 11436 |
|
|
2020
Q4 | $31K | Sell |
1,446
-2,779
| -66% | -$66K | ﹤0.01% | 10838 |
|
|
2020
Q3 | $114K | Buy |
+4,225
| New | +$134K | ﹤0.01% | 9839 |
|
|
2020
Q1 | – | Sell |
-1,363
| Closed | -$51K | – | 10612 |
|
|
2019
Q4 | $51K | Buy |
+1,363
| New | +$49K | ﹤0.01% | 9339 |
|
|
2017
Q1 | – | Sell |
-728
| Closed | -$31K | – | 9513 |
|
|
2016
Q4 | $31K | Buy |
+728
| New | +$41.8K | ﹤0.01% | 9372 |
|
|
2016
Q1 | – | Sell |
-208
| Closed | -$34K | – | 9388 |
|
|
2015
Q4 | $34K | Sell |
208
-224
| -52% | -$41.1K | ﹤0.01% | 9164 |
|
|
2015
Q3 | $97K | Sell |
432
-1,358
| -76% | -$341K | ﹤0.01% | 9154 |
|
|
2015
Q2 | $502K | Buy |
1,790
+1,240
| +225% | +$461K | ﹤0.01% | 7630 |
|
|
2015
Q1 | $210K | Sell |
550
-119
| -18% | -$64.5K | ﹤0.01% | 8568 |
|
|
2014
Q4 | $378K | Buy |
669
+381
| +132% | +$259K | ﹤0.01% | 7749 |
|
|
2014
Q3 | $239K | Sell |
288
-36
| -11% | -$31.5K | ﹤0.01% | 8370 |
|
|
2014
Q2 | $317K | Buy |
324
+66
| +26% | +$64.2K | ﹤0.01% | 8278 |
|
|
2014
Q1 | $273K | Buy |
258
+59
| +30% | +$64K | ﹤0.01% | 7734 |
|
|
2013
Q4 | $204K | Buy |
+199
| New | +$197K | ﹤0.01% | 8238 |
|
Other funds holding LSTA
YCM
CL
DAM
RC
VF
GS
Jeff Yass's LSTA Position: Q2 2026 in Review
Jeff Yass sold out of Lisata Therapeutics (LSTA) in Q2 2026, closing a stake of 11,604 shares — an estimated $58.1K sold.
Jeff Yass first reported a position in LSTA in Q4 2013 and held it in 23 quarters. The position peaked at $502K in Q2 2015. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.
- Jeff Yass reported no remaining Lisata Therapeutics position as of Q2 2026 after selling out during the quarter.
- Jeff Yass sold 11,604 Lisata Therapeutics shares in Q2 2026, an estimated $58.1K.
- Jeff Yass first reported a position in Lisata Therapeutics in Q4 2013 and held it in 23 quarters.
- Jeff Yass's Lisata Therapeutics position peaked at $502K in Q2 2015.
- 31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.